Antibody-drug Conjugate Information
General Information of This Antibody-drug Conjugate (ADC)
| ADC ID |
DRG0VCLTP
|
|||||
|---|---|---|---|---|---|---|
| ADC Name |
TW201803600A ADC-1
|
|||||
| Synonyms |
ADC-1
Click to Show/Hide
|
|||||
| Organization |
SEAGEN INC.
|
|||||
| Drug Status |
Investigative
|
|||||
| Drug-to-Antibody Ratio |
2-5
|
|||||
| Structure |
|
|||||
| Antibody Name |
h2H12
|
Antibody Info | ||||
| Antigen Name |
Myeloid cell surface antigen CD33 (CD33)
|
Antigen Info | ||||
| Payload Name |
PBD
|
Payload Info | ||||
| Therapeutic Target |
Deoxyribonucleic acid (DNA)
|
Target Info | ||||
| Linker Name |
Mc-Val-Ala
|
Linker Info | ||||
| Conjugate Type |
Random conjugation through reduced inter-chain cysteines.
|
|||||
| Combination Type |
TW201803600A-ADC-1-linker-PBD
|
|||||